Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tyrosine kinases are a large family of enzymes that catalyze the transfer of phosphate groups from ATP to tyrosine residues on protein substrates, a process known as phosphorylation. This modification is crucial for regulating cellular signaling pathways involved in growth, differentiation, metabolism, and survival. The family includes receptor tyrosine kinases (RTKs), transmembrane proteins activated by ligand binding, and non-receptor tyrosine kinases, located in the cytoplasm or nucleus, that participate in signal transduction cascades. Aberrant tyrosine kinase activity is implicated in numerous diseases, particularly cancer.
Inhibition of tyrosine kinase activity, blocking downstream signaling pathways.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Tyrosine Kinases (TKs).